Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD

NCT00370539 Phase 3 UNKNOWN

To compare the efficacy and safety of photodynamic therapy (PDT) combined with intravitreal bevacizumab versus combination of photodynamic therapy , intravitreal bevacizumab and intravitreal triamcinolone for neovascular AMD.

Details

Lead sponsor	Shahid Beheshti University of Medical Sciences
Phase	Phase 3
Status	UNKNOWN
Start date	2006-09
Completion	2006-11

Conditions

• Neovascular Age-Related Macular Degeneration

Interventions

• verteporfin, bevacizumab, triamcinolone acetonide

Primary outcomes

• Visual acuity

Countries

Iran